Skip to content

A prospective, single-centre, randomised, parallel-controlled study of the early use of glucocorticoids after microvascular decompression of the facial nerve for the prevention of delayed facial palsy

A prospective, single-centre, randomised, parallel-controlled study of the early use of glucocorticoids after microvascular decompression of the facial nerve for the prevention of delayed facial palsy

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088560
Enrollment
Unknown
Registered
2024-08-21
Start date
2024-10-01
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

delayed facial palsy

Interventions

Intervention Group:Day of surgery, postoperative day 1, postoperative day 2: dexamethasone injection 10mg qd vgtt Postoperative days 3-9: Prednisone acetate tablets 30mg qd po Postoperative days 10-16
Control Group:Postoperative days 2-16: vitamin B1 tablet 10mg tid po Postoperative day 2-16: methylcobalamin tablet 0.5mg tid po

Sponsors

Xinhua Hospital Affilated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for primary hemifacial spasm; 2. Aged 18-80 years old; 3. Undergo facial nerve microvascular decompression surgery for the first time; 4. Willing to participate in this clinical study and sign the informed consent form for the clinical study.

Exclusion criteria

Exclusion criteria: 1. Facial paralysis within 24 hours after surgery; 2. Allergy to glucocorticoids; 3. contraindications to glucocorticoid application (if there is a history of gastric and duodenal ulcers, glaucoma, hypertension, thrombosis, myocardial infarction, visceral surgery, electrolyte metabolism abnormalities, etc., this will be judged on a case-by-case basis by the clinician); 4. history of ipsilateral facial paralysis; 5. the presence of intracranial or extracranial organic lesions that may cause ipsilateral facial paralysis; 6. previous ipsilateral nerve-related surgery; 7. cognitive impairment, dementia, severe mental illness; 8. pregnant or breastfeeding women 9. poor patient compliance and inability to co-operate with medication; 10. participation in other clinical studies within 3 months;

Design outcomes

Primary

MeasureTime frame
Number of cases of delayed facial paralysis between 24 hours and 30 days after surgery;

Secondary

MeasureTime frame
The Facial Disability Index (FDI) Scale;Facial nerve function (the House-Brackmann system);

Countries

China

Contacts

Public ContactLi Shiting

Xinhua Hospital Affilated to Shanghai Jiaotong University School of Medicine

lishiting@xinhuamed.com.cn+86 21 2507 8001

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026